Utomilumab (PF 05082566) is a humanized IgG2 antibody targeting the T-cell co-stimulatory receptor 4-1BB/CD137 and a 4-1BB/CD137 agonist.Utomilumab has antitumor activity and may be used in the study of patients with advanced malignancies.
Molecular Weight:
388.42
CAS Number:
[1417318-27-4]
Formula:
C17H24N8O3
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted